Trial intelligence / Profile preview

Vasopressin for Early Postoperative Management After Fontan Palliation

NCT03088345Phase 3Completed

Sponsor
Medical College of Wisconsin
Start
Mar 2017
Primary completion
Nov 2018
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of vasopressin in low cardiac output syndrome (LCOS), sponsored by Medical College of Wisconsin. Started Mar 2017; status: completed.

02

Drugs

vasopressin
03

Conditions

low cardiac output syndrome (LCOS)

Beyond the preview

Go deeper on NCT03088345.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03088345.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call